[New trend in asthma therapy. Already early administration of inhaled corticoids--but low dosage when possible for long-term treatment].
出版信息
MMW Fortschr Med. 2005 Jun 2;147(22):44-5.
PMID:15977634
Abstract
摘要
相似文献
1
2
The treatment of asthma. Part 2. Practical aspects of management.哮喘的治疗。第2部分。管理的实际方面。
Med J Aust. 1985 Nov 11;143(10):453-5.
3
[Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].[改善哮喘治疗的依从性——证据如何以及如何评估效果？]
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S394-7. doi: 10.1055/s-0029-1243049. Epub 2009 Nov 25.
4
5
[Modern management of asthma].[哮喘的现代管理]
MMW Fortschr Med. 2009 Nov 19;151(47):38, 40-2; quiz 43.
6
Asthma.哮喘
Clin Evid. 2002 Jun(7):1325-43.
7
8
9
[Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].[在以患者为中心的参数方面，固定剂量的吸入性糖皮质激素/长效β2受体激动剂联合制剂有优势吗？]
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S381-5. doi: 10.1055/s-0029-1243046. Epub 2009 Nov 25.
10
Long-acting beta-agonists and inhaled corticosteroids: is the whole greater than the sum of its parts?长效β受体激动剂与吸入性糖皮质激素：整体是否大于部分之和？
J Allergy Clin Immunol. 2010 Feb;125(2):357-8. doi: 10.1016/j.jaci.2009.12.021.
Zotero 插件